Trial NCT00905398

View at ClinicalTrials.gov 
Org. Study IDs: BrALL 01-08
Secondary IDs: 25351732040200851 ANVISA

Last trial update was posted on 2015-07-09

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Lymphoid Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia

Stopping Reasons

The study was terminated due to excessive toxicity and low compliance to the protocol scheme.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID